Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00251381
Status:
UNKNOWN
Last Update Posted:
2006-10-26
First Post:
2005-11-09
Brief Title:
Cetuximab Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma
Sponsor:
Trial Form Support SL
Organization:
Trial Form Support SL
Organization Data
Organization:
Trial Form Support SL
Class:
OTHER
Study ID:
62202-655
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Trial Form Support SL
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck KGaA Darmstadt Germany | INDUSTRY |